Selective degeneration of dopaminergic neurons by MPP+and its rescue by D2 autoreceptors inDrosophilaprimary culture

The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca2+-triggered permeability transition of mitochondria

(2010) Suhel Parvez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

(2010) Paolo Calabresi et al.   LANCET NEUROLOGY

The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons

(2010) Hakeem O. Lawal et al.   NEUROBIOLOGY OF DISEASE

Quantitative analysis of synaptic boutons in Drosophila primary neuronal cultures

(2009) Kauroon Darya et al.   BRAIN RESEARCH

The fluorescent protein palette: tools for cellular imaging

(2009) Richard N. Day et al.   CHEMICAL SOCIETY REVIEWS

Can we achieve neuroprotection with currently available anti-parkinsonian interventions?

(2009) C. W. Olanow   NEUROLOGY

Dopamine Receptor Agonists for Protection and Repair in Parkinsons Disease

(2008) Giulia Ferrari-Toninelli et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Identification ofDrosophilatype II neuroblast lineages containing transit amplifying ganglion mother cells

(2008) Jason Q. Boone et al.   Developmental Neurobiology

D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways

(2008) Sheng Chen et al.   FEBS LETTERS

Differential Modulation of Akt/Glycogen Synthase Kinase-3β Pathway Regulates Apoptotic and Cytoprotective Signaling Responses

(2008) Venugopalan D. Nair et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: Novel cytoprotective mechanism against oxidative damage

(2008) Ju Hee Lim et al.   PHARMACOLOGICAL RESEARCH